Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
Chen
Yingmao
Y
Department of Nuclear Medicine, General Hospital of PLA, Beijing 100853, China. chen.ym@263.net
Geng
Jianhua
J
Tian
Jiahe
J
He
Yijie
Y
Chen
Shengzu
S
D000818:Animals; D001610:Beta Particles / Q000627:therapeutic use*; D049109:Cell Proliferation / Q000528:radiation effects; D002470:Cell Survival / Q000528:radiation effects; D003198:Computer Simulation; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007267:Injections; D008954:Models, Biological; D015233:Models, Statistical; D009369:Neoplasms / Q000378:metabolism / Q000532:radiotherapy*; D011868:Radioisotopes / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011874:Radiometry / Q000379:methods*; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000493:pharmacokinetics; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D016019:Survival Analysis; D016896:Treatment Outcome; D014410:Tumor Stem Cell Assay / Q000379:methods*
D011868:Radioisotopes; D019275:Radiopharmaceuticals